Introduction. Thymus plays an important role in the maturation of T-lymphocytes and in the development of immune tolerance. Its involution comes after puberty. If thymic tissue remains preserved in an advanced age it is considered to be the thymus persistens. According to the available data, 5% of patients with a thymoma have some of the autoimmune disorders. Medical data on the systemic lupus erythematosus (SLE) association with the thymus persistens are scarce. Case report. A 29-year-old patient was diagnosed with SLE at the age of 12. She was treated with continuous doses of corticosteroids and an antimalarial drug (chloroquine). After ten years, the first, and then two more recurrences of the disease with the last recurrence in 2011 occurred. The performed laboratory analyses indicated the disease activity. The radiography of thorax showed a change on the right lung, with enlarged mediastinal shadow. Therefore the multislice computed tomography (MSCT) of thorax was made. The pathohistology findings confirmed that the change on the right lung was focus of chronic pneumonitis, while the change in mediastinum was thymus persistens. The thymectomy was performed. Due to pneumonitis, the treatment of SLE was continued with corticosteroids, antimalarial drug and pulse doses of cyclophosphamide. The patient received six monthly and six quarterly pulsed doses of the drug. The remission of the disease maintained all the time. Conclusion. The disorder of thymic function should be considered as a possible cause in the development of SLE. Though the effect of thymectomy is difficult to assess, patients should be carefully monitored.
Introduction
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease caused by unknown etiology. Its main characteristic is a tissue and cell damage, which is caused by immune complexes and pathogenic autoantibodies. A disorder of immune response regulation with a development of the phenomenon of autoimmunity plays an important role in the pathogenesis. The disease is characterized by the permanent creation of pathogenic autoantibodies to certain cellular components as well as by the formation of immune complexes. A hyperactivity of autoreactive B-and T-cells is expressed, which is caused by a series of disorders. A clinical profile of this multisystem disease is quite diverse. At the beginning, it may appear either as a disease of one organ or as a multisystem disease. Skin, joints, serous membranes, hematopoietic tissue, kidneys and central nervous system are the most frequently affected 1 . The thymus plays an important role in the maturation of T lymphocytes and in the development of immune tolerance. The thymus function disorder is often a cause of some autoimmune diseases 2 . Thymomas are the most common tumors of the anterior mediastinum 3 . The percutaneous needle biopsy or parasternotomy are usually used as diagnostic tools of this tumor, after radiographic examination of the thorax. This diagnostic reveals thymoma in cytological or histological findings. The association of SLE and thymoma is something which is known these days 4, 5 . We report a case of a patient with SLE who was diagnosed the thymus persistens.
Case report
A 29-year-old patient was diagnosed with SLE at the age of 12 based on polyarthralgia, skin changes, bicytopenia (leuko-lymphopenia and thrombocytopenia) and positive antinuclear antibodies (ANA). She was treated with continuous doses of corticosteroids and an antimalarial drug. After ten years there was the first, and then two more recurrences of the disease. She was hospitalized in the Clinic for (TBB), looked like chronic pneumonitis, while findings of percutaneous needle biopsy of the change in mediastinum did not confirm thymoma. Consilium decided to do mediastinoscopy and an open biopsy of described changes in the lung and changes in the mediastinum. Obtained histopathologic findings (ex tempore) of the change in the lungs were consistent with chronic lymphocytic infiltrate without the elements for the malignant disease, and histopathological findings of the change in the mediastinum were consistent with thymus persistens. The thymectomy was done. During hospitalization, the patient was treated with increasing doses of corticosteroids (up to 1 mg/kg body weight). Having in mind the entire course of the disease, and that pneumonitis within the SLE was radiographically and histopathologically confirmed, as well as histopathologically verified thymus persistens, it was decided to continue with the treatment using Cyclophosphamide pulse therapy (15 mg/kg body weight), corticosteroids and an antimalarial drug (chloroquine). The patient received six monthly and six quarterly pulsed doses of cyclophosphamide and a satisfactory therapeutic effect was achieved.
Discussion
The reviews of patients with SLE and thymoma are rare in medical literature. According to the available medical data, 2 cases of thymoma and SLE were published by Cayla et al. 6 in 1975), and 11 more cases were described in the literature from 1922 to 1975. Searching MEDLINE for the period from 1975 to 1998, we identified another 18 cases of thymoma and SLE. The incidence of SLE patients with thymoma is 1.5% to 2% in clinical trials and 6% to 10% with retrospectively biopsy proven thymoma 7 . The importance of these deviations is even higher having in mind a primary role of the thymus in the immune system. It is possible that the increased activity of the thymus is associated with an immune disorder, as a predisposing factor which leads to transformation into tumor 8, 9 . Documentation about the circulating thymus hormone which level in immunodeficient patients (including those with SLE) is decreased, also indicates an association between autoimmune conditions and abnormality of the thymus 10 . The presence of thymoma is found in 30% of patients with clinically manifested SLE while in 30% of cases it was discovered by accident, radiographically, as it was a case with our patient. The clinical picture of SLE is clearly visible, including all immunoserological activity indicators 5, 6, [10] [11] [12] [13] . For the final diagnosis, given the example of our patient, we found that an additional diagnostics was necessary, such as bronchoscopy with TBB and needle biopsy of changes in the mediastinum. The definitive diagnosis was obtained after mediastinoscopy by histopathological biopsy analysis of changes in the mediastinum and lungs. The thymectomy was also performed. The condition of the lungs was the reason for increasing the dose of corticosteroids to 1 mg/kg. This corresponded to the literature data that the effectiveness of the corticosteroid immunosuppressive therapy was satisfactory in these disorders. The presented course of the disease in our patient when pneumonitis within SLE was radiographically and histopathologically confirmed and thymus persistens verified, was an indication to start the therapy with cyclophosphamide pulse therapy at a dose of 15 mg/kg. Thymectomy is recommended in the treatment of thymoma, but we cannot say with certainty how significant it is in the treatment of SLE. According to available literature data, the effect of thymectomy is not clear. Obviously, it does not have an effect on the immunoserological activity in SLE. This indicates that thymus is not the only cause of immunology disorders in SLE. But, a disorder of thymic function, associated with an immune disorder, as a predisposing factor, can lead to the tumor transformation 4, 7, 8 . Based on cases published in the medical literature, SLE is not an indication for thymectomy, but the clinical results showed disease remission after thymectomy in 27.8% of cases 11 . This was the case with our patient, too. However, the connection between the disorder of thymic function and SLE deserves attention and additional studies, especially when the therapeutic effects of thymectomy are considered 5, 8, 10, 13 .
Conclusion
The example of our patient shows that disorder of thymic function should be considered in the etiology of autoimmune diseases, including SLE. The effect of thymectomy is difficult to assess. But, the reduction of the impaired immunological activity can be expected, considering the primary role of the thymus in the immune system. Therefore, such patients should be monitored carefully in order to identify potential factors that could affect the course of SLE.
